CometReports
  • Home
  • Morning Updates
  • Earnings Outlook
  • Analysts Ratings
  • Stocks Review
No Result
View All Result
  • Home
  • Morning Updates
  • Earnings Outlook
  • Analysts Ratings
  • Stocks Review
No Result
View All Result
CometReports
No Result
View All Result

Putting The Spotlight On Affimed N.V. (AFMD)

Edison Carroll Edison by Edison Carroll Edison
May 26, 2023
in Business
0

Affimed N.V. (NASDAQ:AFMD) currently has a daily average trading volume of 745.08K but it saw 1157421 shares traded on Thursday. With a market cap of 116.86M USD, stock’s current market price of $0.87 came falling about -10.07 while comparing to the previous closing price of $0.97. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.40 and as low as $0.55. In the recent trading on the day, stock has struck highest price mark of $1.0028 while lowest mark touched by it was $0.86.

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.

Sponsored

Taking a look at 20-day trading activity of Affimed N.V. (AFMD) gives us an average price of $0.9185, while its current price level is -74.31% below from 52-week high level whereas it is 58.74% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.8254 while that of 200 days or SMA-200 reads an average of $1.5076. A closer look into the stock’s movement over the week reveals that its volatility is standing at 11.80% during that period while stretching the period over a month that decreases to 9.09%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 46.78 which implies that the stock is in neutral territory.

Affimed N.V. (AFMD)’s stock is currently under the radar of 9 analysts who are in consensus at a 12-month price target range of between $0.93 and $12.06 for company’s shares. The average price target assigned by the average number of analysts to a stock is a way to gauge worth of any stock in next 52 weeks. And in assigning price target to a stock, some analysts adopt a bearish approach by advocating lower-than-average price target which in this case is $0.93 while some adopt bullish approach by assigning higher-than-average price target which reads the price to top $12.06. Average price target assigned by them is $6.08 which highlights an upside potential of 85.69% for the stock over that period. And to attain the median price target of $5.57 assigned by those analysts, stock has to add about 84.38% of value to its current levels.

Data by FactSet Research shows that 9 analysts have issued their ratings for the stock. 0 of them are in opinions that stock is a Sell, while 0 are advising it as an Overweight. 8 analysts suggested the investors to Buy the stock while 1 advised them to Hold. Recommendations by all of those brokerages imply a consensus rating of Buy for the stock and that issued by Wall Street to investors is Strong Buy.

Over the week, AFMD’s stock price is moving -9.72% down while it is -5.88% when we observe its performance for the past one month. Year-to-date it is -29.56% down and over the past year, the stock is showing a downside performance of -72.01%.

The latest quarterly earnings report issued by the company was for quarter ended 3/30/2023, when its quarterly earnings per share (EPS) of -$0.23 beaten by the consensus estimate of -$0.21 for the same. The company is expected to be releasing its next quarterly report in 08/09/2023, for which analysts forecasted an EPS of -$0.21 while estimate for next year EPS is -$0.83. For AFMD, analysts are forecasting an EPS-growth rate of -27.70% for current year and estimate for EPS growth in next year is 16.90%. In next quarter, company is expected to be making quarterly sales of $5.05 million as analysts are expecting the sales for current fiscal year at $21.03 million and seeing the company making $15.18 million in sales next year. Moreover, analysts are in estimates of $4.77 million for current-quarter revenue.

Currently, Affimed N.V.’s total number of outstanding shares is 149.34M with 4.70% of that held by the insiders while 61.92% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -51.50% and return on equity (ROE) at -53.40%. Stock’s beta reads 2.50. Stock has a price to book (P/B) ratio of 0.79 while price to sale or P/S ratio amounts to 2.63. Its return on asset (ROA) is -38.60% on average.

A filing at the U.S. Securities and Exchange Commission revealed that iShares Russell 2000 ETF came shrinking its share ownership by -1.44% in the Affimed N.V. (AFMD) decreasing its stake to 2.09% with control over 45600.0 shares in the company.

Tags: Affimed N.V.AFMDAFMD stockNASDAQ:AFMD
Previous Post

Ideas And Forecasts On Lightspeed Commerce Inc. (NYSE: LSPD)

Next Post

Super Group (SGHC) Limited (SGHC) Reports -58.05% Fall From For 52 Week High, It’s Always Darkest Before The Dawn

Edison Carroll Edison

Edison Carroll Edison

Next Post

Super Group (SGHC) Limited (SGHC) Reports -58.05% Fall From For 52 Week High, It's Always Darkest Before The Dawn

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent News

Should You Sell The AZEK Company Inc. (AZEK) And Go Away This Year?

June 8, 2023

Evelo Biosciences Inc. (NASDAQ: EVLO) Bulls Still Eyeing Towards $2.00

June 8, 2023

Aurinia Pharmaceuticals Inc. (AUPH) Down -21.73% From Its 52-Week High, But Growth Potential Is Changing Over Time

June 8, 2023

Neogen Corporation (NASDAQ: NEOG) Recovers 84.65% From 52-Week Low, Is NEOG Still A High-Risk, High-Reward Play?

June 8, 2023

ABOUT US
Become an active part of this community! We will be happy about any activity related to the transfer of your information experience. Write stories about your travels, share opinions about cities, countries and places of interest. Get answers to any questions related to news, scientific projects, travel and other things, and answer them yourself.

Categories

  • Morning Updates
  • Earnings Outlook
  • Analysts Ratings
  • Stocks Review
  • Business
  • Technology and Energy

Company

  • Home
  • About us
  • Contact Us

Recent Posts

  • Should You Sell The AZEK Company Inc. (AZEK) And Go Away This Year?
  • Evelo Biosciences Inc. (NASDAQ: EVLO) Bulls Still Eyeing Towards $2.00
  • Aurinia Pharmaceuticals Inc. (AUPH) Down -21.73% From Its 52-Week High, But Growth Potential Is Changing Over Time

Copyright © 2022 Comet Reports

No Result
View All Result
  • About us
  • Contact Us
  • Home

Copyright © 2022 Comet Reports